View Single Post
Old 06-14-2006, 10:48 PM   #2
rosie
Senior Member
 
Join Date: May 2006
Posts: 26
There is a drug being studied by genentech called Omnitarg that is in very early trials. i can't remember the specifics but it hits more than just the her 2 receptor. But I think this is a number of years away.
rosie is offline   Reply With Quote